Skip to main content
lexblog.com/lib/75XSDWR6viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2020",
    "url": "https://www.lexblog.com/2020/12/29/year-in-review-top-u-s-biosimilars-related-regulatory-developments-of-2020/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-75XSDWR6",
        "url": "https://www.lexblog.com/lib/75XSDWR6/"
    },
    "datePublished": "2020-12-29T15:23:12-05:00",
    "dateModified": "2020-12-29T16:12:06-05:00",
    "author": {
        "@type": "Person",
        "name": "Big Molecule Watch"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Goodwin Procter"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Big Molecule Watch",
    "about": "Administrative and Regulatory ยท Health Care and Life Sciences",
    "sourceUrl": "https://www.bigmoleculewatch.com/2020/12/29/year-in-review-top-u-s-biosimilars-related-regulatory-developments-of-2020/",
    "sourceStability": "may-move"
}